What is a stock summary page? Click here for an overview.
Business Description

Transgene SA
NAICS : 541720
ISIN : FR0005175080
Compare
Compare
Traded in other countries / regions
TNG.FranceTGNA.Germany0OCQ.UKTRGNF.USA IPO Date
2008-05-19Description
Transgene SA is a biotechnology company. The Company conducts its business exclusively in the clinical research and development of therapeutic vaccines and immunotherapeutic products. The company's clinical-stage programs are TG4010 for non-small cell lung cancer and Pexa-vec for liver cancer. Its product pipeline includes TG4001, TG1050, TG6002 etc. It is engaged in clinical research and development of therapeutic vaccines and immunotherapeutic products. The majority of its operations is located in France.
Financial Strength
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 170.22 | |||||
Equity-to-Asset | -0.01 | |||||
Debt-to-Equity | -0.15 | |||||
Piotroski F-Score | 1/9 | |||||
Altman Z-Score | -2.8 | |||||
Beneish M-Score | -1.68 | |||||
WACC vs ROIC |
Growth Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -30.7 | |||||
3-Year EBITDA Growth Rate | -6.9 | |||||
3-Year EPS without NRI Growth Rate | -1.6 | |||||
3-Year FCF Growth Rate | -1.8 | |||||
3-Year Book Growth Rate | -36.5 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 137.54 |
Momentum Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 17.25 | |||||
9-Day RSI | 29.66 | |||||
14-Day RSI | 36.46 | |||||
3-1 Month Momentum % | 2.86 | |||||
6-1 Month Momentum % | -35.71 | |||||
12-1 Month Momentum % | -31.1 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.57 | |||||
Quick Ratio | 1.57 | |||||
Cash Ratio | 1.26 | |||||
Days Sales Outstanding | 6586.7 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -6.4 | |||||
Shareholder Yield % | 1.61 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Operating Margin % | -61256.86 | |||||
Net Margin % | -44923.53 | |||||
FCF Margin % | -76219.61 | |||||
ROE % | -185.99 | |||||
ROA % | -47.23 | |||||
ROIC % | -99.5 | |||||
3-Year ROIIC % | 15.4 | |||||
ROC (Joel Greenblatt) % | -174.13 | |||||
ROCE % | -60.23 | |||||
Years of Profitability over Past 10-Year | 1 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Forward PE Ratio | 12.36 | |||||
PS Ratio | 57.24 | |||||
EV-to-EBIT | -3.3 | |||||
EV-to-EBITDA | -3.51 | |||||
EV-to-Revenue | 1434.15 | |||||
EV-to-FCF | -1.96 | |||||
Price-to-GF-Value | 1.33 | |||||
Price-to-Median-PS-Value | 0.79 | |||||
Earnings Yield (Greenblatt) % | -30.37 | |||||
FCF Yield % | -43.99 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Transgene SA Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | 0.051 | ||
EPS (TTM) (€) | -0.22 | ||
Beta | 1.34 | ||
3-Year Sharpe Ratio | -1.13 | ||
3-Year Sortino Ratio | -1.32 | ||
Volatility % | 34.48 | ||
14-Day RSI | 36.46 | ||
14-Day ATR (€) | 0.007799 | ||
20-Day SMA (€) | 0.70645 | ||
12-1 Month Momentum % | -31.1 | ||
52-Week Range (€) | 0.68 - 1.488 | ||
Shares Outstanding (Mil) | 132.29 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 1 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Transgene SA Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Transgene SA Stock Events
Event | Date | Price (€) | ||
---|---|---|---|---|
No Event Data |
Transgene SA Frequently Asked Questions
What is Transgene SA(LTS:0OCQ)'s stock price today?
The current price of LTS:0OCQ is €0.68. The 52 week high of LTS:0OCQ is €1.49 and 52 week low is €0.68.
When is next earnings date of Transgene SA(LTS:0OCQ)?
The next earnings date of Transgene SA(LTS:0OCQ) is .
Does Transgene SA(LTS:0OCQ) pay dividends? If so, how much?
Transgene SA(LTS:0OCQ) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |